Obesity Facts and Information

Anti-obesity product safe in mid-stage study

NEW YORK (Reuters) – Amylin Pharmaceuticals Inc said on Thursday a mid-stage study of its combination obesity product involving versions of hormones linked to appetite and metabolism yielded positive results. The Phase 2, 28-week study randomized 608 overweight or obese patients to either placebo or various doses of the product, which contains the compounds pramlintide [...]

Continue reading...